Orange Book

Teva Loses Inhaler Patent Case Against Amneal, Must Delete or Amend Orange Book Listing
BioSpace
Wed, 06/12/24 - 11:24 pm
Teva Pharmaceutical
ProAir HFA
FDA
Orange Book
legal
Amneal
FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta
Medical Marketing and Media
Fri, 05/3/24 - 11:10 am
FTC
patents
Orange Book
Novo Nordisk
Ozempic
GSK
Trelegy Ellipta
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
Tue, 11/7/23 - 11:08 pm
FTC
Orange Book
patents
AbbVie
AstraZeneca
Boehringer Ingelheim
FTC eyes crackdown on improper drug patents in FDA's Orange Book
Fierce Pharma
Fri, 09/8/23 - 10:16 am
FDA
FTC
Orange Book
patents
Jazz loses appeal, will have patent delisted from the Orange Book
Endpoints
Mon, 02/27/23 - 07:09 pm
Jazz Pharma
Orange Book
narcolepsy
generics
legal
Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book
Endpoints
Thu, 12/15/22 - 11:04 pm
legal
Orange Book
Jazz Pharma
FDA
patents
narcolepsy
Xyrem
FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition
FTC
Sun, 11/13/22 - 06:56 pm
legal
FTC
Orange Book
Jazz Pharmaceuticals
Avadel Pharma
patents
competition
FDA explains transfer of ownership policy for generics
RAPS.org
Sat, 08/29/20 - 11:49 pm
FDA
Orange Book
generics
FDA looks to overhaul Orange Book, seeks input on patent listings
RAPS.org
Sat, 05/30/20 - 07:49 pm
FDA
Orange Book
patents
Court Finds Sanofi Improperly Listed Insulin Device Patent in FDA’s Orange Book
RAPS.org
Mon, 02/17/20 - 11:19 pm
Sanofi
FDA
patents
insulin
Orange Book
House Unanimously Passes Bills Updating FDA’s Orange and Purple Books
RAPS.org
Wed, 05/8/19 - 05:21 pm
Orange Book
generics
Purple Book
biosimilars
FDA